AMGEN INC is 92.7x more valuable than ADMA BIOLOGICS, INC. by market capitalization ($182.28 B vs $1.97 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ADMA | AMGN |
|---|---|---|
| Market cap | $1.97 B | $182.28 B |
| US-listed rank | #2111 | #80 |
| Revenue (latest FY) | $510.17M | $36.75B |
| Net income (latest FY) | $146.93M | $7.71B |
| Net margin | 28.8% | 21.0% |
| P/E (trailing FY) | 13.4 | 23.6 |
| SEC filings | 988 | 1,011 |
AMGEN INC is 92.7x more valuable than ADMA BIOLOGICS, INC. by market capitalization ($182.28 B vs $1.97 B).
In their latest fiscal years, ADMA BIOLOGICS, INC. reported $510.17M in revenue while AMGEN INC reported $36.75B.
Full pages: ADMA BIOLOGICS, INC. and AMGEN INC, or browse the full rankings.